I wouldn't be surprised if the second round of samples that are tested in the coming weeks come back quite good. Did they hit the vein in the first lot of sampling? Did they hit the vein in the second lot of sampling? Is it correct that they downgraded the operation? Yes. But only at this stage. I am holding and anticipating much better results on round two of the samples. If they are what they wanted, this will produce even better buying opportunities. I would hate to sell my holding without seeing the next batch of results.I'm backing the team to generate a sound result. Do Ashburton renegotiate the deal, possibly. I believe more news is to come from this and possibly very good news.
Never buy a stock on my thoughts. It may cause you terrible capital gains tax problems.........
Add to My Watchlist
What is My Watchlist?